…বাংলা
Barlekha Today logo
All the big stories — in your language, updated every 15 minutes
Home › Health › News
Health

E coli toxin colibactin is leading suspect in rise in bowel cancer among under-50s, scientists tell MPs

Staff Reporter
E coli toxin colibactin is leading suspect in rise in bowel cancer among under-50s, scientists tell MPs
Photo: Collected

Exposure in early life to colibactin, a toxin produced by some variants of E coli bacteria in the gut, has emerged as a leading suspect in the rise of bowel cancer among people under 50, scientists have told a parliamentary committee in Britain.

Cases of early onset bowel cancer have doubled in many countries in the past two decades. Rising obesity and a fall in physical activity are contributors, but researchers believe other factors must also be involved.

Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that known risk factors for colorectal cancer, such as obesity, smoking and alcohol, can explain only about half of the cases doctors diagnose. He said it was not plausible that the rise in early onset bowel cancer could be entirely explained by risk factors researchers already knew about.

Last year scientists identified colibactin, produced by some variants of E coli bacteria in the gut, as a potential driver of early onset colorectal cancer. Hallmark mutations caused by the toxin were three times more common in tumours from people under 40 than in tumours from people over 70.

More work is needed to understand whether colibactin actually drives bowel cancer, but scientists are now actively pursuing the question. Smith-Byrne told MPs that it is probably the leading explanation at the moment.

Prof Mike Stratton at the Sanger Institute, who was not at the hearing, has said colibactin causes mutations in some children but not others, with evidence of mutations appearing as early as infancy. By the age of 10, his work showed, affected children can have a similar mutational burden to a 50-year-old.

Smith-Byrne said that if colibactin is causing mutations, it is doing so at a sensitive period earlier in life, and that can give a person's colon or rectum a head start on its journey towards becoming cancerous. Smith-Byrne is himself a survivor of early onset rectal cancer.

Some suspect that particular variants of E coli that normally live harmlessly in the gut have evolved in recent decades to produce colibactin. Prof Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee that colibactin is essentially found in people born after 1960. Something has happened in the E coli bacteria, he said; there must have been a mutation, and there is a new bacteria.

Bowel cancer is the third most common cancer in the world, accounting for about one in 10 of all cases. The disease is still far more common in the over-50s, but global figures suggest diagnoses are rising steeply in younger people.

Prof Helen Coleman, a cancer epidemiologist at Queen's University Belfast, told MPs that colibactin was the first new clue in quite some time, but its potential role in bowel cancer was still under investigation. Even though adults are diagnosed between 18 and 49, she said, the exposure is quite likely to be in very early life, possibly even in the prenatal period, which makes it very difficult to study.

Riboli said that while scientists need to uncover the unknown drivers of different cancers, people should minimise risks that are already clear. In Britain and the United States, drinking and smoking are both falling, but obesity is rising and physical activity is in decline. The quick win, he said, could come from applying what is known; about 60 percent of cancers occurring now could be prevented, but society is not applying what it knows.

Get the news firstNew stories in your inbox — subscribe free.

More in Health